Skip to main content

Table 1 Laboratory findings

From: Combined effect of teriparatide and low-intensity pulsed ultrasound for nonunion: a case report

 

Normal value

Before teriparatide administration

After teriparatide administration

BAP (μg/ml)

(3.7-20.9)

25.4

19.9

PINP (μg/ml)

(19.5-71.2)

37.1

48.0

DPD (nmol/mmlCr)

(2.1-5.4)

18.7

6.9

Serum NTX (NMOLBCE/L)

(9.5-17.7)

17.6

16.6

TRACP-5B (μU/dl)

(170–590)

446

272

ucOC (ng/ml)

(<4.5)

18.8

5.6

Serum Hcys (nmol/ml)

(3.7-13.5)

21.9

10.9

Urine Pen (μg/mgCr)

(0.019-0.070)

0.042

0.023

intactPTH (pg/ml)

(10–65)

57

54

25-OHVitD (ng/ml)

(7–41)

7

10

Vit.B12 (pg/ml)

(180–914)

700

981

Vit.B6 (ng/ml)

(6–40)

7.2

15.2

Folate (ng/ml)

(>3.1)

2.0

4.2

Ca (mg/dL)

(8.4-9.7)

8.6

9.1

P (mg/dL)

(2.5-4.5)

2.9

2.7

Cr (mg/dL)

(0.6-1.2)

0.9

0.9

eGFR (ml/min/1.73 m2)

(>90)

98

97

CRP (mg/dL)

(<0.3)

0.0

0.0

  1. Abbreviation; BAP Bone alkaline phosphatase, PINP procollagen typeIN-terminal propeptide, DPD dihydropyrimidine dehydrogenase, NTX N-terminal crosslinking telopeptide of typeIcollagen, TRACP-5B Tartrate-resistant Acid Phosphatase type 5B, ucOC uncarboxylated osteocalcin, Hcys homocysteine, Pen pentosidine, PTH parathyroid hormone, 25-OHVitD 25-hydroxyvitamin-D, Ca calcium, P phosphorus, Cr creatinine, CRP C-reactive protein, eGFR estimated glomerular filtration rate.